Autopsy report · NCT01756820

Single-portal Endoscopic Carpal Tunnel Release Versus Knifelight for Carpal Tunnel Syndrome. A Randomized Control Trial

“The principal investigator of the study relocated to another institution.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

University of Ioannina

Sponsor type

University, hospital or other

Conditions

Carpal Tunnel Syndrome

Interventions

Single-portal Endoscopic Carpal Tunnel Release (Microaire®); Knifelight

Participants

0

Sites

1

Countries

Greece

Trials that died the same way

• A Study of Oral L-citrulline in Sickle Cell Disease
  “Principal Investigator moved to another institution” (84% match in meaning)
• A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease
  “Principal Investigator has moved to another institution” (82% match in meaning)
• Dupilumab Phase 4 Study
  “Investigator moved from institution.” (81% match in meaning)
• Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?
  “The researcher and principal investigator working on this study left the institution.” (79% match in meaning)
• Controlled Trial on Effect of Montelukast Treatment in Children With Obstructive Sleep Apnea Syndrome
  “Principal Investigator has transferred to another Institution” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.